WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
600789 Shandong Lukang Pharmaceutical
- 11.33
- +0.18+1.61%
Market Closed Apr 3 15:00 CST
10.18BMarket Cap25.81P/E (TTM)
11.97High11.18Low2.33MlotVolume11.18Open11.15Pre Close2.70BTurnover25.92%Turnover Ratio25.81P/E (Static)898.67MShares12.7052wk High2.60P/B10.18BFloat Cap5.5652wk Low12.27Limit Up898.67MShs Float19.42Historical High10.04Limit Down7.09%Amplitude0.54Historical Low0.11Dividend TTM11.58Avg Price1.11MlotAsk0.97%Div YieldTTM100Lot Size1.10MlotBid
Shandong Lukang Pharmaceutical Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.41%6.23B | -1.37%4.67B | 2.93%3.28B | 7.72%1.8B | 9.34%6.15B | 16.75%4.73B | 18.66%3.19B | 25.42%1.67B | 14.17%5.62B | 13.39%4.05B |
| Operating revenue | 1.41%6.23B | -1.37%4.67B | 2.93%3.28B | 7.72%1.8B | 9.34%6.15B | 16.75%4.73B | 18.66%3.19B | 25.42%1.67B | 14.17%5.62B | 13.39%4.05B |
| Other operating revenue | -13.67%68.85M | ---- | -32.42%34.94M | ---- | 4.25%79.76M | ---- | 29.29%51.7M | ---- | 62.02%76.51M | ---- |
| Total operating cost | 1.00%5.97B | -0.57%4.55B | 3.55%3.18B | 7.62%1.74B | 8.29%5.91B | 15.32%4.57B | 17.35%3.07B | 25.57%1.62B | 13.81%5.46B | 15.18%3.96B |
| Operating cost | 2.34%4.74B | 0.39%3.65B | 1.95%2.54B | 8.66%1.37B | 5.88%4.63B | 15.35%3.63B | 18.40%2.49B | 23.37%1.26B | 16.76%4.37B | 17.39%3.15B |
| Operating tax surcharges | 1.52%54.58M | -1.31%38.63M | 19.31%29.12M | 29.01%15.44M | 5.03%53.76M | 11.64%39.14M | 20.35%24.41M | 11.31%11.97M | 34.55%51.19M | 34.20%35.06M |
| Operating expense | -1.65%568.07M | -6.81%422.55M | 7.85%307.82M | 1.25%201.91M | 21.58%577.59M | 13.47%453.41M | 19.71%285.4M | 48.18%199.42M | -1.85%475.09M | 7.84%399.58M |
| Administration expense | 0.65%234.13M | -1.94%167.74M | 11.27%113.32M | 13.88%55.45M | 9.25%232.62M | 26.82%171.05M | 16.47%101.84M | 12.05%48.69M | 11.48%212.93M | 3.43%134.88M |
| Financial expense | -19.58%53.59M | 1.92%45.24M | 65.66%24.02M | -28.74%17.58M | -14.78%66.64M | -11.33%44.39M | -52.18%14.5M | 42.66%24.68M | 14.73%78.2M | -0.59%50.06M |
| -Interest expense (Financial expense) | -4.79%75.38M | 3.64%57.16M | 8.59%36.77M | -0.71%19.03M | -19.25%79.17M | -24.54%55.15M | -15.24%33.86M | 33.92%19.17M | 50.54%98.04M | 43.69%73.09M |
| -Interest Income (Financial expense) | -39.56%-12.48M | -36.74%-8.85M | -28.80%-6.11M | -26.94%-2.24M | -24.39%-8.94M | -13.84%-6.47M | -26.02%-4.74M | 4.61%-1.76M | -3.81%-7.19M | 8.96%-5.69M |
| Research and development | -8.28%317.15M | -2.83%223.17M | 8.12%158.89M | 11.92%80.66M | 30.98%345.79M | 18.10%229.68M | 12.39%146.96M | 19.76%72.07M | -0.76%264M | 7.55%194.48M |
| Credit Impairment Loss | -275.60%-13.7M | -150.98%-10.28M | -224.37%-13.96M | -193.20%-7.08M | 138.10%7.8M | 223.91%20.16M | 205.37%11.22M | 242.88%7.6M | 17.14%-20.48M | 26.78%-16.27M |
| Asset Impairment Loss | -22.42%-66.94M | 129.29%3.52M | 80.94%-4.86M | 116.71%1.79M | -30.39%-54.68M | -2.94%-12.01M | -571.27%-25.52M | -1,555.84%-10.74M | -35.54%-41.94M | -4.22%-11.67M |
| Adjustment items of total operating cost | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | 414.20%170.08M | 310.49%251.49M | 608.16%217.21M | 3,935.21%20.21M | 291.20%33.08M | 396.03%61.27M | 479.84%30.67M | -90.77%500.92K | -20.33%-17.3M | 190.27%12.35M |
| Fair value change income | 142.86%29.52K | 216.67%46.74K | -348.00%-152.52K | -583.33%-71.34K | -233.33%-68.88K | 220.00%14.76K | 725.00%61.5K | -89.29%14.76K | -54.35%51.66K | -350.00%-12.3K |
| Invest income | -6.40%-7.59M | -55.86%-5.91M | -95.30%-3.88M | -95.30%-1.77M | -8.39%-7.13M | -83.09%-3.79M | -47.20%-1.99M | -17.11%-907.46K | -99.68%-6.58M | -31.43%-2.07M |
| -Including: Investment income associates | -7.04%-7.67M | -55.86%-5.91M | -95.30%-3.88M | -95.30%-1.77M | -8.43%-7.17M | -83.09%-3.79M | -47.20%-1.99M | -17.11%-907.46K | -100.63%-6.61M | -31.43%-2.07M |
| Asset deal income | 54,305.58%153.42M | 98,040.85%155.94M | 167,209.48%155.94M | -31.65%63.71K | -90.04%282K | -94.24%158.89K | 25,367.03%93.2K | 143,004.91%93.2K | 1,719.78%2.83M | 3,633.38%2.76M |
| Other revenue | 20.70%104.86M | 90.67%108.18M | 79.74%84.12M | 514.37%27.28M | 77.99%86.88M | 43.23%56.74M | 121.82%46.8M | -63.09%4.44M | 10.17%48.81M | 85.28%39.61M |
| Adjusted Items effecting operating profit | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 60.29%436.19M | 68.43%372.54M | 114.71%320.17M | 46.27%80.58M | 82.92%272.13M | 119.90%221.18M | 95.43%149.12M | 8.98%55.09M | 28.23%148.77M | -14.99%100.58M |
| Add:Non operating Income | 39.67%1.68M | 27.94%962.91K | 83.06%780.1K | 152.04%347.56K | -57.56%1.21M | -43.20%752.61K | -57.46%426.13K | -4.55%137.9K | 30.22%2.84M | -38.80%1.32M |
| Less:Non operating expense | 992.28%3.97M | 1,143.45%1.18M | -66.91%30.64K | -75.35%11.64K | -76.05%363.63K | 140.78%94.51K | 127.77%92.6K | 149.21%47.23K | -67.14%1.52M | -89.73%39.25K |
| Total profit | 58.95%433.9M | 67.84%372.33M | 114.73%320.92M | 46.64%80.92M | 81.87%272.98M | 117.77%221.84M | 93.43%149.45M | 8.88%55.18M | 32.15%150.1M | -15.18%101.87M |
| Less:Income tax cost | 57.86%25.55M | -29.61%15.41M | 3.51%14.2M | 28.10%9.95M | 131.91%16.19M | 205.97%21.89M | 116.92%13.72M | 69.24%7.77M | -70.53%6.98M | -75.46%7.15M |
| Net profit | 59.02%408.35M | 78.51%356.92M | 125.98%306.71M | 49.67%70.97M | 79.43%256.79M | 111.11%199.95M | 91.34%135.73M | 2.87%47.41M | 59.21%143.11M | 4.15%94.71M |
| Net profit from continuing operation | 59.02%408.35M | 78.51%356.92M | 125.98%306.71M | 49.67%70.97M | 79.43%256.79M | 111.11%199.95M | 91.34%135.73M | 2.87%47.41M | 59.21%143.11M | 4.15%94.71M |
| Less:Minority Profit | 29.36%13.73M | 33.35%9.86M | 55.20%6.75M | 111.98%3.66M | 108.07%10.62M | 137.61%7.39M | 92.29%4.35M | 54.67%1.73M | 543.65%5.1M | 22.37%3.11M |
| Net profit of parent company owners | 60.30%394.62M | 80.24%347.06M | 128.32%299.96M | 47.32%67.31M | 78.37%246.17M | 110.21%192.55M | 91.31%131.38M | 1.59%45.69M | 54.90%138.01M | 3.63%91.6M |
| Earning per share | ||||||||||
| Basic earning per share | 57.14%0.44 | 77.27%0.39 | 120.00%0.33 | 60.00%0.08 | 75.00%0.28 | 120.00%0.22 | 87.50%0.15 | 0.00%0.05 | 60.00%0.16 | 0.00%0.1 |
| Diluted earning per share | 57.14%0.44 | 85.71%0.39 | 135.71%0.33 | 60.00%0.08 | 86.67%0.28 | 110.00%0.21 | 75.00%0.14 | 0.00%0.05 | 50.00%0.15 | 11.11%0.1 |
| Other composite income | -44.72%-7.45M | 36.03%-2.43M | 36.03%-2.43M | -28.29%-5.15M | -120.20%-3.8M | -120.20%-3.8M | 12.52%-4.01M | -23.31%-1.73M | ||
| Other composite income of parent company owners | -44.72%-7.45M | 36.03%-2.43M | 36.03%-2.43M | ---- | -28.29%-5.15M | -120.20%-3.8M | -120.20%-3.8M | ---- | 12.52%-4.01M | -23.31%-1.73M |
| Total composite income | 59.31%400.9M | 80.73%354.49M | 130.64%304.28M | 49.67%70.97M | 80.90%251.64M | 110.94%196.15M | 90.62%131.93M | 2.87%47.41M | 63.07%139.1M | 3.85%92.99M |
| Total composite income of parent company owners | 60.63%387.16M | 82.58%344.63M | 133.22%297.53M | 47.32%67.31M | 79.87%241.02M | 110.02%188.75M | 90.56%127.58M | 1.59%45.69M | 58.56%134M | 3.31%89.87M |
| Total composite income of minority owners | 29.36%13.73M | 33.35%9.86M | 55.20%6.75M | 111.98%3.66M | 108.07%10.62M | 137.61%7.39M | 92.29%4.35M | 54.67%1.73M | 543.65%5.1M | 22.37%3.11M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.